CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 29, 2025	Jun. 30, 2024	Jun. 29, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenue		$ 7,468	$ 3,768	$ 12,566	$ 9,040
Cost of revenue		5,526	4,423	10,363	11,495
Gross profit (loss)		1,942	(655)	2,203	(2,455)
Operating expenses:
Research and development		28,148	29,065	54,077	77,853
Selling, general and administrative		17,527	20,884	34,419	40,432
Restructuring cost		0	38,146	0	38,146
Total operating expenses		45,675	88,095	88,496	156,431
Loss from operations		(43,733)	(88,750)	(86,293)	(158,886)
Other income (expense):
Change in fair value of common stock warrants		(5,885)	(33,660)	9,911	(12,540)
Gain on bargain purchase of assets		4,761	0	4,761	0
Interest income		2,427	3,326	4,861	6,886
Interest expense		(1,705)	(1,691)	(3,421)	(3,350)
Other income (loss), net		(992)	242	1,361	708
Total other income (loss), net		(1,394)	(31,783)	17,473	(8,296)
Loss before income tax benefit		(45,127)	(120,533)	(68,820)	(167,182)
Income tax benefit		(861)	(4,586)	(1,023)	(4,738)
Net loss		(44,266)	(115,947)	(67,797)	(162,444)
Net gain (loss) attributable to non-controlling interests		262	(75)	241	(204)
Net loss attributable to Enovix		$ (44,528)	$ (115,872)	$ (68,038)	$ (162,240)
Net loss per share attributable to Enovix shareholders, basic (in dollars per share)	[1]	$ (0.22)	$ (0.63)	$ (0.33)	$ (0.90)
Net loss per share attributable to Enovix shareholders, diluted (in dollars per share)	[1]	$ (0.22)	$ (0.63)	$ (0.33)	$ (0.90)
Weighted average number of common shares outstanding, basic (in shares)	[1]	204,819,119	183,256,633	204,086,108	180,995,568
Weighted average number of common shares outstanding, diluted (in shares)	[1]	204,819,119	183,256,633	204,086,108	180,995,568

[1] As required by ASC 260, Earnings Per Share, the share and per share amounts for the periods presented above in the condensed consolidated financial statements have been retroactively adjusted to reflect the warrant dividends issued in July 2025. For warrant dividends, please refer to Note 14 “Subsequent Events” for more details.